Stable serum pepsinogen I determination kit, and preparation method and application thereof

A technology of pepsinogen and kits, applied in measuring devices, instruments, scientific instruments, etc., can solve the problems of susceptibility to the influence of chylomicrons (CM), inconvenient storage of reagents, and low analytical sensitivity, so as to enhance anti-interference ability , Excellent performance indicators, simple operation effect

Active Publication Date: 2021-01-22
中拓医学检验有限公司 +1
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Double-antibody sandwich immunochemiluminescence assay (ILMA) has high accuracy and sensitivity, but the equipment is expensive, reagents are inconvenient to store, and the price is high; colloidal gold colorimetry is simple to operate and produces fast results, but it can only be used for qualitative research and cannot Quantitative
Latex immunoturbidimetric method has the advantages of high specificity, simple and quick operation, accurate and safe, automatic analysis, and low cost. ) impact and other shortcomings, the present invention improves the shortcomings of the existing pepsinogen I kit to meet the requirements of clinical testing and chemical analysis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stable serum pepsinogen I determination kit, and preparation method and application thereof
  • Stable serum pepsinogen I determination kit, and preparation method and application thereof
  • Stable serum pepsinogen I determination kit, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] A conventional pepsinogen I assay kit, which includes reagent R1 and reagent R2.

[0052] Reagent R1 contains the following ingredients:

[0053] Piperazine-1,4-diethanesulfonic acid (PIPES) buffer solution 50mmol / L;

[0054] NaCl 9g / L;

[0055] Sodium hydroxide 0.1g / L;

[0056] Propylene glycol fatty acid ester 1%;

[0057] Polyoxyethylene Sorbitan Hexa Stearate 1%;

[0058] proclin300 1 ml / L.

[0059] Reagent R1 has a pH value of 7.2.

[0060] Reagent R2 contains the following ingredients:

[0061] Piperazine-1,4-diethanesulfonic acid (PIPES) buffer solution 50mmol / L;

[0062] Mouse anti-human PGI antibody coated latex particles 30mg / L;

[0063] Bovine serum albumin (BSA) 5g / L;

[0064] Polyvinylpyrrolidone k30 5g / L;

[0065] Mannitol 5g / L;

[0066] Glycerol 10ml / L;

[0067] Triton 100 1%;

[0068] proclin300 1ml / L.

[0069] Reagent R2 has a pH of 6.8.

[0070] Wherein said percentage is volume ratio.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

The invention provides a pepsinogen I (PGI) determination kit. The kit contains a reagent R1 and a reagent R2, the reagent R1 contains the following components: a piperazine 1, 4-diethylsulfonic acid(PIPES) buffer solution, NaCl, sodium hydroxide, a surfactant and a preservative, and the reagent R2 comprises the piperazine-1, 4-diethylsulfonic acid (PIPES) buffer solution, mouse anti-human PGI antibody coated latex particles, a suspending aid, a stabilizer and the preservative. The invention also provides a preparation method and application of the kit. The kit can effectively avoid the interference of chyle particles, different types of protective agents and suspending agents are adopted at the same time, and the kit is a liquid kit with strong stability, high sensitivity, good repeatability and low cost.

Description

technical field [0001] The invention relates to the technical field of biochemical reagent assay, in particular to a pepsinogen I assay kit, and also to a preparation method and application of the pepsinogen I assay kit. Background technique [0002] Pepsinogen (pepsinogen), synthesized by the main cells of the oxyntic gland, becomes pepsin in the gastric cavity through the action of hydrochloric acid (HCL) or active pepsin (pepsin), and decomposes protein into fat, peptone and a small amount of peptides . The optimum pH for the enzyme action is 2, and the enzyme activity is lost after entering the small intestine. [0003] Pepsinogen is the precursor of pepsin. According to its biochemical properties and immunogenicity, it is divided into 2 subgroups. The immunogenicity of components 1-5 is the same, called pepsinogen I, which is mainly composed of fundic glands. Secreted by chief cells and mucus neck cells; components 6 and 7 are called pepsinogen II, in addition to bein...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/573G01N33/543G01N33/539
CPCG01N33/539G01N33/54313G01N33/573
Inventor 刘安娜
Owner 中拓医学检验有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap